{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:14:31Z","timestamp":1758636871290},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.vph.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:42:25Z","timestamp":1527169345000},"page":"74-76","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Impact of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and lactation: a focus on short and long-term vascular effects"],"prefix":"10.1016","volume":"108","author":[{"given":"S.","family":"Zullino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vph.2018.05.008_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant Drug Effects and Depression Severity","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2018.05.008_bb0010","series-title":"Boston University, Slone Epidemiology Center","author":"Slone Epidemiology Center Birth Defect Study","year":"2018"},{"issue":"6","key":"10.1016\/j.vph.2018.05.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.vph.2018.05.008_bb0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tins.2016.11.009","article-title":"The neurobiology of postpartum anxiety and depression","volume":"40","author":"Pawluski","year":"2017","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.vph.2018.05.008_bb0025","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/1471-0528.13143","article-title":"Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions","volume":"122","author":"Charlton","year":"2015","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"issue":"8","key":"10.1016\/j.vph.2018.05.008_bb0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.vph.2018.05.008_bb0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.reprotox.2018.02.004","article-title":"Perinatal selective serotonin reuptake inhibitor (SSRI) effects on body weight at birth and beyond: a review of animal and human studies","volume":"77","author":"Hutchison","year":"2018","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.vph.2018.05.008_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/17425255.2018.1430139","article-title":"Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects","volume":"14","author":"Ornoy","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.vph.2018.05.008_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00002018-200528020-00005","article-title":"The safety of newer antidepressants in pregnancy and breastfeeding","volume":"28","author":"Gentile","year":"2005","journal-title":"Drug Saf."},{"key":"10.1016\/j.vph.2018.05.008_bb0050","series-title":"Long-Term Effects of Breastfeeding\u2014A Systematic Review","author":"World Health Organization (WHO)","year":"2013"},{"key":"10.1016\/j.vph.2018.05.008_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14767058.2018.1455180","article-title":"Selective serotonin reuptake inhibitors passage into human milk of lactating women","author":"Pogliani","year":"2018","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"5697","key":"10.1016\/j.vph.2018.05.008_bb0060","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1101678","article-title":"Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice","volume":"306","author":"Ansorge","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vph.2018.05.008_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neubiorev.2017.04.023","article-title":"Perinatal selective serotonin reuptake inhibitor medication (SSRI) effects on social behaviors, neurodevelopment and the epigenome","volume":"85","author":"Gemmel","year":"2018","journal-title":"Neurosci. Biobeh. Rev."},{"issue":"1","key":"10.1016\/j.vph.2018.05.008_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000103097","article-title":"Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation","volume":"80","author":"Lisboa","year":"2007","journal-title":"Pharmacology"},{"key":"10.1016\/j.vph.2018.05.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2017.5227","article-title":"Association between brain structure and connectivity in infants and exposure to selective serotonin reuptake inhibitors during pregnancy","author":"Lugo-Candelas","year":"2018","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.vph.2018.05.008_bb0080","doi-asserted-by":"crossref","DOI":"10.1089\/jwh.2017.6642","article-title":"Prenatal selective serotonin reuptake inhibitor use and associated risk for gestational hypertension and preeclampsia: a meta-analysis of cohort studies","author":"Guan","year":"2018","journal-title":"J. Womens Health (Larchmt)"},{"issue":"11","key":"10.1016\/j.vph.2018.05.008_bb0085","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4088\/JCP.15m10506","article-title":"Prenatal psychostimulant and antidepressant exposure and risk of hypertensive disorders of pregnancy","volume":"77","author":"Newport","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.vph.2018.05.008_bb0090","article-title":"Strategy for standardization of preeclampsia research study design","volume":"64","author":"Myatt","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2018.05.008_bb0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2010","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.vph.2018.05.008_bb0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/uog.15741","article-title":"Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy","volume":"48","author":"Ferrazzi","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"S","key":"10.1016\/j.vph.2018.05.008_bb0105","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA senior award lecture: making sense of pre-eclampsia","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"issue":"S","key":"10.1016\/j.vph.2018.05.008_bb0110","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.placenta.2013.12.003","article-title":"IFPA award in placentology lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease","volume":"35","author":"Staff AC","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.vph.2018.05.008_bb0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1196\/annals.1376.036","article-title":"Maternal depression and psychotropic medication effects on the human fetus","volume":"1094","author":"Emory","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.vph.2018.05.008_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1203\/00006450-200204000-00007","article-title":"Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth","volume":"51","author":"Morrison","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.vph.2018.05.008_bb0125","first-page":"1599","article-title":"Fluoxetine may worsen hyperoxia-induced lung damage in neonatal rats","volume":"27","author":"Porzionato","year":"2012","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.vph.2018.05.008_bb0130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1164\/rccm.200701-163OC","article-title":"Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat","volume":"176","author":"Fornaro","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.vph.2018.05.008_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045294","article-title":"Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction","volume":"7","author":"Pisaneschi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2018.05.008_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2018.04.004","article-title":"Intrauterine and lactational exposure to fluoxetine enhances endothelial modulation of aortic contractile response in adult female rats","author":"Higashi","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2018.05.008_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.reprotox.2018.02.004","article-title":"Perinatal selective serotonin reuptake inhibitor (SSRI) effects on body weight at birth and beyond: a review of animal and human studies","volume":"77","author":"Hutchison","year":"2018","journal-title":"Reprod. Toxicol."},{"issue":"Suppl. 3","key":"10.1016\/j.vph.2018.05.008_bb0155","first-page":"629","article-title":"What are the risks associated with different selective serotonin re-uptake inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence","volume":"29","author":"Womersley","year":"2017","journal-title":"Psychiatr. Danub."},{"issue":"1","key":"10.1016\/j.vph.2018.05.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010130","article-title":"Decisions about the use of psychotropic medication during pregnancy: a qualitative study","volume":"6","author":"Stevenson","year":"2016","journal-title":"BMJ Open"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189118301848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189118301848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T01:02:14Z","timestamp":1531789334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189118301848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"alternative-id":["S1537189118301848"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2018.05.008","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and lactation: a focus on short and long-term vascular effects","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2018.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}